IL202465A0 - Sildenafil n-oxide as prodrug - Google Patents

Sildenafil n-oxide as prodrug

Info

Publication number
IL202465A0
IL202465A0 IL202465A IL20246509A IL202465A0 IL 202465 A0 IL202465 A0 IL 202465A0 IL 202465 A IL202465 A IL 202465A IL 20246509 A IL20246509 A IL 20246509A IL 202465 A0 IL202465 A0 IL 202465A0
Authority
IL
Israel
Prior art keywords
sildenafil
prodrug
oxide
Prior art date
Application number
IL202465A
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of IL202465A0 publication Critical patent/IL202465A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL202465A 2007-06-26 2009-12-02 Sildenafil n-oxide as prodrug IL202465A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94619807P 2007-06-26 2007-06-26
EP07111030 2007-06-26
PCT/EP2008/057940 WO2009000798A1 (en) 2007-06-26 2008-06-23 Sildenafil n-oxide as prodrug

Publications (1)

Publication Number Publication Date
IL202465A0 true IL202465A0 (en) 2010-06-30

Family

ID=39758764

Family Applications (1)

Application Number Title Priority Date Filing Date
IL202465A IL202465A0 (en) 2007-06-26 2009-12-02 Sildenafil n-oxide as prodrug

Country Status (7)

Country Link
EP (1) EP2170895A1 (en)
KR (1) KR20100050488A (en)
AU (1) AU2008267274A1 (en)
CA (1) CA2690294A1 (en)
EA (1) EA201070056A1 (en)
IL (1) IL202465A0 (en)
WO (1) WO2009000798A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010006227A (en) 2010-06-07 2011-12-14 World Trade Imp Exp Wtie Ag Novel 1,4-diazepam pde-5 inhibitor derivatives.
AT512084A1 (en) 2011-10-20 2013-05-15 Univ Wien Tech DIAZABICYCLO AND DIAZASPIRO ALKAN DERIVATIVES AS PHOSPHODIESTERASE-5 INHIBITORS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU734734B2 (en) * 1997-10-28 2001-06-21 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
CA2475377A1 (en) * 2002-02-07 2003-08-14 Pfizer Inc. Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome

Also Published As

Publication number Publication date
KR20100050488A (en) 2010-05-13
EP2170895A1 (en) 2010-04-07
WO2009000798A1 (en) 2008-12-31
EA201070056A1 (en) 2010-06-30
AU2008267274A1 (en) 2008-12-31
CA2690294A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
HK1223512A1 (en) Smoking tool
IL212244A0 (en) Nicotine immunonatherapeutics
DK200800103A (en) Integreret føringskant for vindturbineblad
EP2231376A4 (en) Tool for forming construct
HK1157784A1 (en) Quinoxalinedione derivatives
GB0716849D0 (en) Improved tool
IL199726A0 (en) Iron-carbohydrate complex compounds
HK1139129A1 (en) 18f-labelled folates 18f-
GB2455986B (en) Retaining formation
IL201248A0 (en) 18f - labelled folates
EP2200774A4 (en) Multi-purpose beveller
HK1207857A1 (en) 18f-labelled folates 18f-
GB0809621D0 (en) Planer
GB0712557D0 (en) Improved tools
GB2449551B (en) Improved planer
GB0712130D0 (en) Planer
GB0723387D0 (en) Improved dehumldifier
IL202465A0 (en) Sildenafil n-oxide as prodrug
ZA200908868B (en) Sildenafil N-oxide as prodrug
GB0725011D0 (en) Router adjusta-guide
GB0811273D0 (en) Prodrug
GB0716839D0 (en) Woodturning tools
GB0723650D0 (en) Bias controller
GB0711686D0 (en) Ashtray
PL382441A1 (en) Set for dyspersion stability determination